Quarterly report pursuant to Section 13 or 15(d)

Income Taxes (Details)

Income Taxes (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended 12 Months Ended
Mar. 30, 2014
Sep. 29, 2013
Income Tax Disclosure [Abstract]    
Annual effective income tax rate for continuing operations 16.00% 16.00%
Tax benefit related to fiscal 2012 from R&D tax credit extension in fiscal 2013   $ 64
Tax benefits from foreign income taxed at rates lower than rates in the United States 18.00% 17.00%
Unrecognized tax benefits $ 209  
Expected tax benefit resulting from an agreement reached with the IRS the Company expects to record a tax benefit of approximately $65 million in the third quarter of fiscal 2014